Three‐Year Outcome of Drug Coated Balloon Angioplasty Following Atherectomy for Severely Calcified Coronary Lesions
Catheterization and Cardiovascular Interventions · 2025
DOI: 10.1002/ccd.70196 ↗At a glance
Vergleichsstudie in Catheterization and Cardiovascular Interventions, 2025. Written by Taka-Aki Takamura and 11 co-authors. Institution: Department of Cardiology, Kanazawa Medical University, Uchinada, Japan. Major MEDLINE topics: Atherectomy, Coronary, Coronary Artery Disease, Vascular Calcification, Coated Materials, Biocompatible. Cited 1 times so far (Crossref); 20 references. The full text is freely available (open access, CC BY-NC-ND 4.0).
Abstract (original language)
We aimed to compare the long‐term efficacy and safety of drug‐coated balloon (DCB) and drug‐eluting stent (DES) following atherectomy for coronary arteries with severely calcified lesions. Of the 258 consecutive patients and 422 de novo lesions treated with DCB at Kanazawa Medical University Hospital, we retrospectively enrolled highly calcified de novo lesions treated with atherectomy, rotablator, and/or orbital atherectomy system (OAS), followed by the use of either DCB (94 cases, 191 lesions) or DES (159 cases, 216 lesions) were retrospectively examined. The primary endpoint was target lesion revascularization (TLR), and the secondary endpoint was major adverse cardiac event (MACE) during 3 years of follow‐up. Regarding patient background, there was a significant difference in age (All DCB vs. DES: 69.5 ± 11.4 vs. 73.2 ± 8.6; p < 0.001), and the DCB group included more dialysis cases (28.3% vs. 15.3%; p < 0.01). No significant difference was observed in the lesion background. The balloon size of the DCB was 2.56 ± 0.40 mm. Acute closure was not observed after DCB. Late lumen loss (LLL) was −0.07 ± 0.34 mm (DCB) versus 0.46 ± 0.65 mm (DES). Late lumen engagement (LLE) was observed in 56 lesions (56/129 [43.4%]) in the DCB group. As adjunctive treatment after atherectomy for calcified lesions, no significant difference was observed in TLR (16.2% vs. 13.4%; log‐rank, p = 0.08) and MACE (18.3% vs. 16.2%; log‐rank, p = 0.13). For highly calcified coronary lesions, relative to DES, treatment with DCB after atherectomy could provide clinically acceptable favorable results in terms of TLR and MACE at 3 years.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Cardiology, Kanazawa Medical University, Uchinada, Japan.
- Division of Medical Engineer, Kanazawa Medical University, Uchinada, Japan.
ORCID profiles: Taka-Aki Takamura, Taketsugu Tsuchiya
Cite
APA
Takamura, T. A., Nakagawa, C., Masaki, M., Akita, S., Oda, M., Wakasa, M., Akao, H., Kitayama, M., Tsuchiya, T., Ichikawa, T., Takama, S., & Nakagawa, T. (2025). Three‐Year Outcome of Drug Coated Balloon Angioplasty Following Atherectomy for Severely Calcified Coronary Lesions. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.70196
Vancouver
Takamura TA, Nakagawa C, Masaki M, Akita S, Oda M, Wakasa M, et al. Three‐Year Outcome of Drug Coated Balloon Angioplasty Following Atherectomy for Severely Calcified Coronary Lesions. Catheterization and Cardiovascular Interventions. 2025. doi:10.1002/ccd.70196
BibTeX
@article{Takamura2025,
author = {Takamura, Taka-Aki and Nakagawa, Chihiro and Masaki, Miharu and Akita, Satori and Oda, Minako and Wakasa, Minoru and Akao, Hironobu and Kitayama, Michihiko and Tsuchiya, Taketsugu and Ichikawa, Toshiki and Takama, Shunsuke and Nakagawa, Tohru},
title = {Three‐Year Outcome of Drug Coated Balloon Angioplasty Following Atherectomy for Severely Calcified Coronary Lesions},
journal = {Catheterization and Cardiovascular Interventions},
year = {2025},
doi = {10.1002/ccd.70196}
}
EUVIMED